Engineers Gate Manager LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,975
-17.1%
10,162
-1.0%
0.00%
-100.0%
Q2 2023$13,238
-2.3%
10,2620.0%0.00%0.0%
Q1 2023$13,546
-11.1%
10,262
+1.0%
0.00%0.0%
Q4 2022$15,243
-85.2%
10,162
-70.6%
0.00%
-75.0%
Q1 2022$103,000
+28.8%
34,519
+9.8%
0.00%
-42.9%
Q3 2017$80,000
-58.5%
31,434
-55.5%
0.01%
-58.8%
Q2 2017$193,00070,6520.02%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders